Jc. Barrow et al., Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists, BIOORG MED, 11(20), 2001, pp. 2691-2696
Thrombin is the most potent agonist of platelet activation, and its effects
are predominantly mediated by platelet thrombin receptors. Therefore, anta
gonists of the thrombin receptor have potential utility for the treatment o
f thrombotic disorders. Screening of combinatorial libraries revealed 2 to
be a potent antagonist of the thrombin receptor. Modifications of this stru
cture produced 11k, which inhibits thrombin receptor stimulated secretion a
nd aggregation of platelets. (C) 2001 Elsevier Science Ltd. All rights rese
rved.